Skip to main content Accessibility help
×
Home
Hostname: page-component-cf9d5c678-dkwk2 Total loading time: 0.173 Render date: 2021-08-02T10:44:51.613Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Variability between nursing homes in prevalence of antipsychotic use in patients with dementia

Published online by Cambridge University Press:  20 November 2013

Bart C. Kleijer
Affiliation:
Careyn Utrecht, Gerimedica, the Netherlands
Rob J. van Marum
Affiliation:
Geriatric Department, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands
Dinnus H. M. Frijters
Affiliation:
Department of Nursing Home Medicine, VU University Medical Center, Amsterdam, the Netherlands EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands
Paul A. F. Jansen
Affiliation:
Department of Geriatrics, University Medical Center Utrecht, Utrecht, the Netherlands
Miel W. Ribbe
Affiliation:
Department of Nursing Home Medicine, VU University Medical Center, Amsterdam, the Netherlands EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands
Antoine C. G. Egberts
Affiliation:
Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands
Eibert R. Heerdink
Affiliation:
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands
Corresponding
E-mail address:

Abstract

Background:

Antipsychotic drugs (APD) are widely prescribed for people with dementia residing in long term care facilities (LTCFs). Concern has been expressed that such prescribing is largely inappropriate. The objective of this study is to examine if differences in facility-level prevalence of APD use in a sample of LTCFs for patients with dementia can be explained by patient and facility-related characteristics.

Methods:

A point prevalence study was conducted using data from the VU University Resident Assessment Instrument (VURAI) database from nursing homes and residential care facilities in the Netherlands. Patients were selected who had a diagnosis of dementia. LTCF and patient characteristics were extracted from the VURAI; facility-level resident satisfaction surveys were provided by the National Institute for Public Health.

Results:

In total, 20 LTCFs providing care for 1,090 patients with dementia were investigated. Overall, 31% of patients used an APD. In facilities with a high prevalence of APD use behavioral symptoms were present in 62% of their patients. In facilities with medium APD use behavioral problems remained frequent (57%), and in facilities with low prevalence of APD use 54% of the patients had behavioral symptoms. Facilities with a high prevalence of APD use were often large, situated in urban communities, and scored below average on staffing, personal care, and recreational activities.

Conclusions:

There was considerable variation between the participating LTCFs in the prevalence of APD use. Variability was related to LTCF characteristics and patient satisfaction. This indicates potential inappropriate prescribing because of differences in institutional prescribing culture.

Type
Research Article
Copyright
Copyright © International Psychogeriatric Association 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Agency for Healthcare Research and Quality. (2003). Consumer Assessment of Healthcare Providers and Systems (CAHPS). Rockville, MD: Agency for Healthcare Research and Quality.Google ScholarPubMed
Azermai, M., Elseviers, M., Petrovic, M., van Bortel, L. and Stichele, R. V. (2011). Assessment of antipsychotic prescribing in Belgian nursing homes. International Psychogeriatrics, 23, 12401248. doi:S104161021100024X [pii]10.1017/S104161021100024XCrossRefGoogle ScholarPubMed
Beer, C. et al. (2010). Factors associated with self and informant ratings of the quality of life of people with dementia living in care facilities: a cross sectional study. Public Library of Science One, 5, e15621. doi:10.1371/journal.pone.0015621 Google ScholarPubMed
Bronskill, S. E. et al. (2009). The relationship between variations in antipsychotic prescribing across nursing homes and short-term mortality: quality of care implications. Medical Care, 47, 10001008. doi:10.1097/MLR.0b013e3181a3943f CrossRefGoogle ScholarPubMed
Chen, Y., Briesacher, B. A., Field, T. S., Tjia, J., Lau, D. T. and Gurwitz, J. H. (2010). Unexplained variation across US nursing homes in antipsychotic prescribing rates. Archives of Internal Medicine, 170, 8995. doi:170/1/89 [pii]10.1001/archinternmed.2009.469 CrossRefGoogle ScholarPubMed
Cornege-Blokland, E., Kleijer, B. C., Hertogh, C. M. and van Marum, R. J. (2012). Reasons to prescribe antipsychotics for the behavioral symptoms of dementia: a survey in Dutch nursing homes among physicians, nurses, and family caregivers. Journal of the American Medical Directors Association, 13, 80.e81–86. doi:S1525-8610(10)00365-8 [pii]10.1016/j.jamda.2010.10.004CrossRefGoogle ScholarPubMed
Devanand, D. P. et al. (2012). Relapse risk after discontinuation of risperidone in Alzheimer's disease. New England Journal of Medicine, 367, 14971507. doi:10.1056/NEJMoa1114058 CrossRefGoogle ScholarPubMed
Finne-Soveri (2010). Measuring the quality of longterm institutional care in Finland. Eurohealth, 16, 8.Google Scholar
Fossey, J. et al. (2006). Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ, 332, 756761. doi:bmj.38782.575868.7C [pii] 10.1136/bmj.38782.575868.7C CrossRefGoogle ScholarPubMed
Gerritsen, D., Ooms, M., Steverink, N., Frijters, D., Bezemer, D. and Ribbe, M. (2004). Three new observational scales for use in Dutch nursing homes: scales from the Resident Assessment Instrument for Activities of Daily Living, cognition and depression. Tijdschrift voor Gerontologie en Geriatrie, 35, 5564.Google ScholarPubMed
Guthrie, B., Clark, S. A. and McCowan, C. (2010). The burden of psychotropic drug prescribing in people with dementia: a population database study. Age and Ageing, 39, 637642. doi:afq090 [pii]10.1093/ageing/afq090 CrossRefGoogle Scholar
Hartmaier, S. L., Sloane, P. D., Guess, H. A., Koch, G. G., Mitchell, C. M. and Phillips, C. D. (1995). Validation of the Minimum Data Set Cognitive Performance Scale: agreement with the Mini-Mental State Examination. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 50, M128133.CrossRefGoogle ScholarPubMed
Huang, H. L., Chang, M. Y., Tang, J. S., Chiu, Y. C. and Weng, L. C. (2009). Determinants of the discrepancy in patient- and caregiver-rated quality of life for persons with dementia. Journal of Clinical Nursing, 18, 31073118. doi:JCN2537 [pii]10.1111/j.1365-2702.2008.02537.x CrossRefGoogle ScholarPubMed
Hughes, C. M., Lapane, K., Watson, M. C. and Davies, H. T. (2007). Does organisational culture influence prescribing in care homes for older people? A new direction for research. Drugs and Aging, 24, 8193. doi:2421 [pii]CrossRefGoogle ScholarPubMed
Huybrechts, K. F., Rothman, K. J., Silliman, R. A., Brookhart, M. A. and Schneeweiss, S. (2011). Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. Canadian Medical Association Journal, 183, E411419. doi:cmaj.101406 [pii]10.1503/cmaj.101406 Google ScholarPubMed
Hyer, K., Thomas, K. S., Branch, L. G., Harman, J. S., Johnson, C. E. and Weech-Maldonado, R. (2011). The influence of nurse staffing levels on quality of care in nursing homes. Gerontologist, 51, 610616. doi:gnr050 [pii]10.1093/geront/gnr050 CrossRefGoogle ScholarPubMed
Kamble, P., Chen, H., Sherer, J. and Aparasu, R. R. (2008). Antipsychotic drug use among elderly nursing home residents in the United States. American Journal of Geriatric Pharmacotherapy, 6, 187.CrossRefGoogle ScholarPubMed
Kleijer, B. C., et al. (2009). The course of behavioral problems in elderly nursing home patients with dementia when treated with antipsychotics. International Psychogeriatrics, 21, 931940. doi:S1041610209990524 [pii]10.1017/S1041610209990524CrossRefGoogle ScholarPubMed
Koehler, M. et al. (2005). Measuring depression in nursing home residents with the MDS and GDS: an observational psychometric study. Biomed Central Geriatrics, 5, 1. doi:1471-2318-5-1 [pii]10.1186/1471-2318-5-1 Google ScholarPubMed
Morris, J. N. et al. (1997). A commitment to change: revision of HCFA's RAI. Journal of the American Geriatrics Society, 45, 10111016.CrossRefGoogle ScholarPubMed
Nijk, R. M., Zuidema, S. U. and Koopmans, R. T. (2009). Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia. International Psychogeriatrics, 21, 485493.CrossRefGoogle ScholarPubMed
Ray, W. A., Federspiel, C. F. and Schaffner, W. (1980). A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. American Journal of Public Health, 70, 485491.CrossRefGoogle ScholarPubMed
Richter, T., Mann, E., Meyer, G., Haastert, B. and Kopke, S. (2012). Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts. Journal of the American Medical Directors Association, 13, 187.e187–187.e113. doi:S1525-8610(11)00108-3 [pii]10.1016/j.jamda.2011.03.007 CrossRefGoogle ScholarPubMed
Rochon, P. A. et al. (2007). Variation in nursing home antipsychotic prescribing rates. Archives of Internal Medicine, 167, 676683. doi:167/7/676 [pii]10.1001/archinte.167.7.676 CrossRefGoogle ScholarPubMed
Ruths, S., Straand, J. and Nygaard, H. A. (2001). Psychotropic drug use in nursing homes–diagnostic indications and variations between institutions. European Journal of Clinical Pharmacology, 57, 523528.Google ScholarPubMed
Schneider, L. S., Dagerman, K. and Insel, P. S. (2006). Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. American Journal of Geriatric Psychiatry, 14, 191.CrossRefGoogle ScholarPubMed
Shah, S. M., Carey, I. M., Harris, T., Dewilde, S. and Cook, D. G. (2011). Antipsychotic prescribing to older people living in care homes and the community in England and Wales. International Journal of Geriatric Psychiatry, 26, 423434. doi:10.1002/gps.2557 CrossRefGoogle ScholarPubMed
Snowden, M., Sato, K. and Roy-Byrne, P. (2003). Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of the literature. Journal of the American Geriatrics Society, 51, 13051317. doi:51417 [pii]CrossRefGoogle ScholarPubMed
Testad, I. et al. (2010). Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England. International Journal of Geriatric Psychiatry, 25, 725731. doi:10.1002/gps.2414 CrossRefGoogle ScholarPubMed
Tornatore, J. B. and Grant, L. A. (2004). Family caregiver satisfaction with the nursing home after placement of a relative with dementia. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences, 59, S8088.CrossRefGoogle ScholarPubMed
Triemstra, M., Winters, S., Kool, R. B. and Wiegers, T. A. (2010). Measuring client experiences in long-term care in the Netherlands: a pilot study with the Consumer Quality Index Long-term Care. BioMed Central Health Services Research, 10, 95. doi:1472-6963-10-95 [pii]10.1186/1472-6963-10-95 CrossRefGoogle ScholarPubMed
Verbeek, H., van Rossum, E., Zwakhalen, S. M., Kempen, G. I. and Hamers, J. P. (2009). Small, homelike care environments for older people with dementia: a literature review. International Psychogeriatrics, 21, 252264. doi:S104161020800820X [pii]10.1017/S104161020800820X CrossRefGoogle ScholarPubMed
Verbeek, H., Zwakhalen, S. M., van Rossum, E., Ambergen, T., Kempen, G. I. and Hamers, J. P. (2010). Dementia care redesigned: effects of small-scale living facilities on residents, their family caregivers, and staff. Journal of the American Medical Directors Association, 11, 662670. doi:S1525-8610(10)00250-1 [pii]10.1016/j.jamda.2010.08.001CrossRefGoogle Scholar
Vernooij-Dassen, M., Vasse, E., Zuidema, S., Cohen-Mansfield, J. and Moyle, W. (2010). Psychosocial interventions for dementia patients in long-term care. International Psychogeriatrics, 22, 11211128. doi:S1041610210001365 [pii]10.1017/S1041610210001365CrossRefGoogle ScholarPubMed
Zuidema, S. U., de Jonghe, J. F., Verhey, F. R. and Koopmans, R. T. (2011). Psychotropic drug prescription in nursing home patients with dementia: influence of environmental correlates and staff distress on physicians’ prescription behavior. International Psychogeriatrics, 23, 16321639. doi:S1041610211001438 [pii] 10.1017/S1041610211001438CrossRefGoogle ScholarPubMed
27
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Variability between nursing homes in prevalence of antipsychotic use in patients with dementia
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Variability between nursing homes in prevalence of antipsychotic use in patients with dementia
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Variability between nursing homes in prevalence of antipsychotic use in patients with dementia
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *